Dr. Racquel Z. LeGeros, a professor of Biomaterials and Biomimetics and the Linkow Professor of Implant Dentistry, has received a five-year, $3.23
million grant from the National Institutes of Health (NIH) to continue her study of innovative compounds that will be safe, affordable, and effective for the prevention and reversal of bone loss caused by osteoporosis.
"Results from the proposed studies could lead to the development of safe and affordable therapy that will target both prevention and reversal of bone loss due to osteoporosis and other bone-deficient diseases," said Dr. LeGeros. "These results will greatly impact public health and alleviate the tremendous socioeconomic burden associated with osteoporosis."
In her previous work, "Effect of Mg/Zn/F-CaP Supplements on Bone Properties: Phase 1" (October 2007), Dr. LeGeros describes the initial results of her research which showed that calcium phosphate-based formulations administered as a dietary supplement or by injection - even at low concentrations -
significantly improved bone strength and thickness, and prevented bone loss induced by mineral deficiency without the side effects of many current drug treatments.
Current FDA-approved pharmaceutical-based osteoporosis treatments, such as bisphosphonate drugs and hormone therapies, do not effectively repair bone that has already been lost. In fact, bisphosphonates have been shown to actually inhibit bone redevelopment. Many of these treatments also have
serious side effects, including increasing the risk of osteonecrosis of the jaw, delayed fracture healing, heart disease, strokes, and breast cancer.
Dr. LeGeros's coinvestigators are Dr. Mani Alikhani, Assistant Professor of Orthodontics; Dr. Yu Zhang, Assistant Professor of Biomaterials & Biomimetics; Dr. Timothy Bromage, Adjunct Professor of Biomaterials & Biomimetics and of Basic Science & Craniofacial Biology; Dr. John LeGeros, Adjunct Professor of Biomaterials & Biomimetics; Dr. Dindo Mijares, Assistant Research Scientist in Biomaterials & Biomimetics, all at NYUCD; and Dr. Jennifer MacLeay, Associate Professor of Veterinary Medicine, Colorado State University.